How can LLMs be deployed safely in healthcare?

The latest stories trending on MedCity News.

Editor's Pick

Top Story How Can LLMs Be Deployed Safely in Healthcare? Healthcare technology experts have confidence that the industry will put the right guardrails up around LLMs as it continues to develop and deploy these AI tools, they said Sunday during a panel discussion at Engage at HLTH. Sponsored Content Payer's Place: Dawn Maroney, Alignment Health Presented by HLTH and MedCity News Dawn Maroney of Alignment Health highlights how they provide healthcare that helps patients be financially responsible and receive the care needed.  How the company utilizes course data and technology to help advance those needs and connect the patients with better practices and outcomes. Click here to watch the full interview!

Featured News

CVS Exec: We're Going To Find Out if Blue Shield of California's New Drug Model Will Lower Costs Blue Shield of California recently switched up its pharmacy benefit model by distributing responsibilities to several different vendors. The model has the potential to increase drug costs, but it remains to be seen, according to Creagh Milford, SVP of retail health at CVS Health. Takeda to Pull Lung Cancer Drug from Market After Failed Confirmatory Study Takeda Pharmaceutical drug Exkivity failed the confirmatory study required of its 2021 accelerated approval. Our recap of other recent regulatory developments includes a partial clinical hold on a cancer drug, a Covid-19 vaccine authorization, and several drug approvals in the U.S. and beyond. Fostering the Next Generation of Antisense Oligonucleotide Therapies Antisense oligonucleotides (ASOs) have faced their share of challenges, but a combination of research advances and a market ripe for innovation is setting this drug class up for a resurgence. Antisense oligonucleotide (ASO)—a class of drugs that works by targeting RNA to alter gene expression and control aberrant proteins in ways that traditional drugs can't. Digital Hospital of the Future Streamlines Care to Reduce Burdens on Clinicians The most successful implementations of digital solutions offer value propositions on both sides of the equation — they create value for the patient and family, while also making the clinician's job easier and more enjoyable by saving time and eliminating ancillary duties.

Resources

MedCity Pivot Podcast: Tackling Rare Disease With Someone Who Was Touched By It Rich Horgan believes that there's an alternative path to drug development that can lower costs and the time it takes to bring drugs to market. He is trying to apply it to the field of rare and ultra-rare diseases. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe